Optimal Treatment Strategies in Myeloma: An Argument Against Maintenance Therapy after Autologous Stem Cell Transplantation

Despite continuing advancements in novel therapeutics for Multiple Myeloma (MM), high-dose therapy with autologous stem cell rescue continues to represent the standard approach to treat transplant-eligible, newly diagnosed patients [1]. As the disease remains essentially incurable, and median progression-free survivals after autologous transplant are measured in years and not decades, attempts to improve outcomes in the post-transplant setting have been extensive and commonly focused on a “maintenance” approach.
Source: Seminars in Oncology - Category: Cancer & Oncology Authors: Tags: Mailankody: Myeloma Source Type: research